Tag: entrepreneurs
-
New Type of Antibiotic Set for Early Trial
A clinical trial is set to test a type of drug that its developers say is designed to treat infections from bacteria resistant to earlier antibiotics.
-
Trial Testing Stem-Cell Implant for Cartilage Repair
An early clinical trial testing implants of a person’s stem cells to repair damaged knee cartilage in younger adults returned largely favorable results.
-
Stem Cell Therapy Company Formed, Staked to $225M
A pharmaceutical company and health care venture investor are forming BlueRock Therapeutics, a biotechnology enterprise to design regenerative medicine treatments with stem cells.
-
Start-Up Developing Nanotech Bone Repairs
An enterprise formed earlier this year is licensing an engineered bone tissue repair technology that mixes ultrafine diamond particles with biocompatible polymers.
-
LEDs Shown to Reduce Alzheimer’s Brain Plaques
Pulsating LED lights were shown in lab mice to reduce amyloid-beta plaque deposits associated with Alzheimer’s disease on brain cells, with the lead researchers starting a company to commercialize the technology.
-
Start-Up Reprogramming Stem Cells to Treat Heart Failure
A new enterprise, spun-off from the Gladstone Institutes in San Francisco, plans to regenerate heart muscle from other cells to treat heart failure.
-
Company Launches to Discover Gut-Brain Therapies
A California Institute of Technology biologist is starting a new enterprise to discover treatments for neurological disorders through pathways originating in the gut.
-
Partnership Assessing Nerve Stimulation Bleeding Device
The Feinstein Institute for Medical Research and Global Good Fund are evaluating an electronic device that stimulates nerves to stop bleeding, as a way to control postpartum hemorrhage
-
Nanotech Material Found Having Anti-Bacterial Properties
A synthetic porous material developed to deliver drugs to the skin was shown in lab tests to prevent the growth of bacteria on its surfaces.
-
Blood Stem Cell Start-Up Launches, Earns $48.5M Funding
A new enterprise, spun-off from Harvard University stem cell labs, aims to make stem cell transplants from bone marrow safer and more reliable.